Perioperative β-blocker use: what is new in 2020?
Purpose of review
Although the indications for β-blockers in the management of patients with congestive heart failure and myocardial infarction are well established, the use of β-blockers in the perioperative setting remains controversial.
Recent findings
Since 2008 PeriOperative ISchemic Evaluation Trial, there have been numerous studies suggesting that perioperative β-blockers are associated with adverse events such as hypotension, bradycardia, increased mortality, and stroke.
Summary
In this article, we review the most recent evidence to suggest an approach to perioperative β-blocker use tailored to patient and surgical risk factors. We also review recent studies on off-label uses for perioperative β-blockers.
Source: Current Opinion in Anaesthesiology - Category: Anesthesiology Tags: ANESTHESIA AND MEDICAL DISEASE: Edited by Adriana Oprea Source Type: research
More News: Anesthesia | Anesthesiology | Cardiology | Congestive Heart Failure | Heart | Heart Attack | Heart Failure | Ischemic Stroke | Stroke | Study